
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy
Peter S. Hendricks
International Review of Psychiatry (2018) Vol. 30, Iss. 4, pp. 331-342
Closed Access | Times Cited: 143
Peter S. Hendricks
International Review of Psychiatry (2018) Vol. 30, Iss. 4, pp. 331-342
Closed Access | Times Cited: 143
Showing 1-25 of 143 citing articles:
Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety
Alan K. Davis, Frederick S. Barrett, Roland R. Griffiths
Journal of Contextual Behavioral Science (2019) Vol. 15, pp. 39-45
Open Access | Times Cited: 276
Alan K. Davis, Frederick S. Barrett, Roland R. Griffiths
Journal of Contextual Behavioral Science (2019) Vol. 15, pp. 39-45
Open Access | Times Cited: 276
Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies
Joost J. Breeksema, Alistair Niemeijer, Erwin Krediet, et al.
CNS Drugs (2020) Vol. 34, Iss. 9, pp. 925-946
Open Access | Times Cited: 166
Joost J. Breeksema, Alistair Niemeijer, Erwin Krediet, et al.
CNS Drugs (2020) Vol. 34, Iss. 9, pp. 925-946
Open Access | Times Cited: 166
Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression
Meghan Hibicke, Alexus N. Landry, Hannah M. Kramer, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 6, pp. 864-871
Open Access | Times Cited: 162
Meghan Hibicke, Alexus N. Landry, Hannah M. Kramer, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 6, pp. 864-871
Open Access | Times Cited: 162
Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review
Kwonmok Ko, Gemma Knight, James Rucker, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 152
Kwonmok Ko, Gemma Knight, James Rucker, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 152
Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance
Max Wolff, Ricarda Evens, Lea J. Mertens, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 139
Max Wolff, Ricarda Evens, Lea J. Mertens, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 139
Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review
Michiel van Elk, David B. Yaden
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104793-104793
Open Access | Times Cited: 106
Michiel van Elk, David B. Yaden
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104793-104793
Open Access | Times Cited: 106
From Egoism to Ecoism: Psychedelics Increase Nature Relatedness in a State-Mediated and Context-Dependent Manner
Hannes Kettner, Sam Gandy, Eline Haijen, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 24, pp. 5147-5147
Open Access | Times Cited: 107
Hannes Kettner, Sam Gandy, Eline Haijen, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 24, pp. 5147-5147
Open Access | Times Cited: 107
Psychedelic microdosing benefits and challenges: an empirical codebook
Thomas Anderson, Rotem Petranker, Adam Christopher, et al.
Harm Reduction Journal (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 96
Thomas Anderson, Rotem Petranker, Adam Christopher, et al.
Harm Reduction Journal (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 96
Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes
Gabrielle Agin-Liebes, Trevor Forrest Haas, Rafael Lancelotta, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 543-552
Open Access | Times Cited: 93
Gabrielle Agin-Liebes, Trevor Forrest Haas, Rafael Lancelotta, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 543-552
Open Access | Times Cited: 93
Exploring ayahuasca‐assisted therapy for addiction: A qualitative analysis of preliminary findings among an Indigenous community in Canada
Elena Argento, Rielle Capler, Gerald Thomas, et al.
Drug and Alcohol Review (2019) Vol. 38, Iss. 7, pp. 781-789
Closed Access | Times Cited: 90
Elena Argento, Rielle Capler, Gerald Thomas, et al.
Drug and Alcohol Review (2019) Vol. 38, Iss. 7, pp. 781-789
Closed Access | Times Cited: 90
Combining Psychedelic and Mindfulness Interventions: Synergies to Inform Clinical Practice
Jake Payne, Richard Chambers, Paul Liknaitzky
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 416-423
Open Access | Times Cited: 66
Jake Payne, Richard Chambers, Paul Liknaitzky
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 416-423
Open Access | Times Cited: 66
Awe as a Pathway to Mental and Physical Health
María Monroy, Dacher Keltner
Perspectives on Psychological Science (2022) Vol. 18, Iss. 2, pp. 309-320
Open Access | Times Cited: 66
María Monroy, Dacher Keltner
Perspectives on Psychological Science (2022) Vol. 18, Iss. 2, pp. 309-320
Open Access | Times Cited: 66
Shopping with augmented reality: How wow-effect changes the equations!
Vahideh Arghashi
Electronic Commerce Research and Applications (2022) Vol. 54, pp. 101166-101166
Closed Access | Times Cited: 54
Vahideh Arghashi
Electronic Commerce Research and Applications (2022) Vol. 54, pp. 101166-101166
Closed Access | Times Cited: 54
More than meets the eye: The role of sensory dimensions in psychedelic brain dynamics, experience, and therapeutics
Marco Aqil, Leor Roseman
Neuropharmacology (2022) Vol. 223, pp. 109300-109300
Open Access | Times Cited: 44
Marco Aqil, Leor Roseman
Neuropharmacology (2022) Vol. 223, pp. 109300-109300
Open Access | Times Cited: 44
Transformative experience and informed consent to psychedelic-assisted psychotherapy
Edward Jacobs
Frontiers in Psychology (2023) Vol. 14
Open Access | Times Cited: 28
Edward Jacobs
Frontiers in Psychology (2023) Vol. 14
Open Access | Times Cited: 28
Restructuring insight: An integrative review of insight in problem-solving, meditation, psychotherapy, delusions and psychedelics
Kadi Tulver, Karl Kristjan Kaup, Ruben Laukkonen, et al.
Consciousness and Cognition (2023) Vol. 110, pp. 103494-103494
Open Access | Times Cited: 26
Kadi Tulver, Karl Kristjan Kaup, Ruben Laukkonen, et al.
Consciousness and Cognition (2023) Vol. 110, pp. 103494-103494
Open Access | Times Cited: 26
Clinically relevant acute subjective effects of psychedelics beyond mystical experience
David B. Yaden, Sean P. Goldy, Brandon Weiss, et al.
Nature Reviews Psychology (2024) Vol. 3, Iss. 9, pp. 606-621
Closed Access | Times Cited: 11
David B. Yaden, Sean P. Goldy, Brandon Weiss, et al.
Nature Reviews Psychology (2024) Vol. 3, Iss. 9, pp. 606-621
Closed Access | Times Cited: 11
Psychedelic-assisted psychotherapy: where is the psychotherapy research?
Jacob S. Aday, David Horton, Gisele Fernandes‐Osterhold, et al.
Psychopharmacology (2024) Vol. 241, Iss. 8, pp. 1517-1526
Closed Access | Times Cited: 8
Jacob S. Aday, David Horton, Gisele Fernandes‐Osterhold, et al.
Psychopharmacology (2024) Vol. 241, Iss. 8, pp. 1517-1526
Closed Access | Times Cited: 8
Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics
Sam G. Moreton, Luke Szalla, Rachel E. Menzies, et al.
Psychopharmacology (2019) Vol. 237, Iss. 1, pp. 21-32
Closed Access | Times Cited: 66
Sam G. Moreton, Luke Szalla, Rachel E. Menzies, et al.
Psychopharmacology (2019) Vol. 237, Iss. 1, pp. 21-32
Closed Access | Times Cited: 66
Narrative identity, rationality, and microdosing classic psychedelics
Megan Webb, Heith Copes, Peter S. Hendricks
International Journal of Drug Policy (2019) Vol. 70, pp. 33-39
Closed Access | Times Cited: 59
Megan Webb, Heith Copes, Peter S. Hendricks
International Journal of Drug Policy (2019) Vol. 70, pp. 33-39
Closed Access | Times Cited: 59
Awe and the interconnected self
Susan K. Chen, Myriam Mongrain
The Journal of Positive Psychology (2020) Vol. 16, Iss. 6, pp. 770-778
Closed Access | Times Cited: 52
Susan K. Chen, Myriam Mongrain
The Journal of Positive Psychology (2020) Vol. 16, Iss. 6, pp. 770-778
Closed Access | Times Cited: 52
Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings
Carla Pallavicini, Federico Cavanna, Federico Zamberlán, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 4, pp. 406-420
Closed Access | Times Cited: 46
Carla Pallavicini, Federico Cavanna, Federico Zamberlán, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 4, pp. 406-420
Closed Access | Times Cited: 46
Increases in Psychological Flexibility Mediate Relationship Between Acute Psychedelic Effects and Decreases in Racial Trauma Symptoms Among People of Color
Alan K. Davis, Yitong Xin, Nathan D. Sepeda, et al.
Chronic Stress (2021) Vol. 5
Open Access | Times Cited: 45
Alan K. Davis, Yitong Xin, Nathan D. Sepeda, et al.
Chronic Stress (2021) Vol. 5
Open Access | Times Cited: 45
“This Is Something That Changed My Life”: A Qualitative Study of Patients' Experiences in a Clinical Trial of Ketamine Treatment for Alcohol Use Disorders
Özden Merve Mollaahmetoğlu, Johanna Louise Keeler, Katherine J. Ashbullby, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 40
Özden Merve Mollaahmetoğlu, Johanna Louise Keeler, Katherine J. Ashbullby, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 40
Naturalistic use of psychedelics is related to emotional reactivity and self-consciousness: The mediating role of ego-dissolution and mystical experiences
Paweł Orłowski, Anastasia Ruban, Jan Szczypiński, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 8, pp. 987-1000
Open Access | Times Cited: 28
Paweł Orłowski, Anastasia Ruban, Jan Szczypiński, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 8, pp. 987-1000
Open Access | Times Cited: 28